Crossmark

Validity and reliability of the Persian version of illness invalidation inventory (3*I) among patients with non-inflammatory rheumatic painful disorders

Crossref DOI link: https://doi.org/10.1186/s41927-022-00256-0

Published Online: 2022-05-03

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghavidel-Parsa, Banafsheh

Khosousi, Mohammad-Javad

Tohidi, Sepehr

Bidari, Ali

Soltani, Saman

Zayeni, Habib

Montazeri, Ali
License Information

Text and Data Mining valid from 2022-05-03

Version of Record valid from 2022-05-03
More Information

Article History

Received: 13 September 2021

Accepted: 3 March 2022

First Online: 3 May 2022

Declarations

:

: The study was approved by the Ethical Committee of Guilan University of Medical Sciences (IR.GUMS.REC.1398.339). All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all the patients.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below